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Background:  We characterized the diagnostic yield, arrhythmia type, and time to arrhythmia using a national registry of ambulatory ECG data.
Methods: We evaluated the findings of 18,236 consecutive patients in the United States wearing first-time 14-day ambulatory ECG Zio® patch 
monitors (iRhythm Inc, San Francisco, CA) prescribed for clinical indications from October 2010 to October 2011. Arrhythmia adjudication was 
performed and coded by trained Holter technicians, and de-identified data was extracted from a clinical registry for analysis. Episodes were 
classified into three categories based on type of arrhythmia: first, first symptom-triggered, and longest duration.
Results: The mean age was 60±18 years; 54% were female. The mean wear time was 7.1±3.3 days and the median analyzable time was 95%. 
Arrhythmias were identified in 64% of patients with the following prevalence: SVT≥4 beats (77.1%), SVT≥8 beats (51.1%), paroxysmal AF (PAF) 
(16.0%), chronic AF (12.8%), VT≥4 beats (19.9%), VT≥8 beats (7.5%), pause>3 sec (6.2%), Mobitz II or complete AV block (2.2%). After adjustment 
for age, women compared to men were more likely to have SVT detected (OR 1.30, p<0.001) than any of the other arrhythmias (OR 0.50, p<0.001 
for all). Excluding patients with chronic AF, the mean time to first arrhythmia and first symptom-triggered arrhythmia from the start of monitoring was 
40±51 hours and 66±64 hours. For symptomatic episodes, time to first occurrence was longest for VT (82±68h) and SVT (74±64h), followed by PAF 
(62±64h), pauses (53±47h), and AV block (43±54h). 27.6% of first arrhythmias and 41.9% of first symptom-triggered arrhythmias occurred beyond 
48 hours from the start of monitoring.
Conclusions: There was high variation in time to first and first symptomatic arrhythmia; 41.9% of patients had their first symptomatic arrhythmia 
beyond 48 hours from the start of monitoring. Extended (14-day) monitoring can increase diagnostic yield, regardless of arrhythmia type.
